FI972309A0 - 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning - Google Patents

2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning

Info

Publication number
FI972309A0
FI972309A0 FI972309A FI972309A FI972309A0 FI 972309 A0 FI972309 A0 FI 972309A0 FI 972309 A FI972309 A FI 972309A FI 972309 A FI972309 A FI 972309A FI 972309 A0 FI972309 A0 FI 972309A0
Authority
FI
Finland
Prior art keywords
thiadizolidin
heterocyclyloxy
thiomethyl
dioxides
preparation
Prior art date
Application number
FI972309A
Other languages
English (en)
Finnish (fi)
Other versions
FI972309A (sv
Inventor
John J Court
Ranjit C Desai
Dennis J Hlasta
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of FI972309A0 publication Critical patent/FI972309A0/sv
Publication of FI972309A publication Critical patent/FI972309A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cosmetics (AREA)
FI972309A 1994-12-02 1997-05-30 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning FI972309A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/348,421 US5494925A (en) 1994-12-02 1994-12-02 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
PCT/US1995/015563 WO1996016649A1 (en) 1994-12-02 1995-11-30 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof

Publications (2)

Publication Number Publication Date
FI972309A0 true FI972309A0 (sv) 1997-05-30
FI972309A FI972309A (sv) 1997-07-30

Family

ID=23367973

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972309A FI972309A (sv) 1994-12-02 1997-05-30 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning

Country Status (12)

Country Link
US (1) US5494925A (sv)
EP (1) EP0793494A4 (sv)
JP (1) JPH10510535A (sv)
CN (1) CN1173130A (sv)
AU (1) AU703719B2 (sv)
CA (1) CA2205970A1 (sv)
FI (1) FI972309A (sv)
HU (1) HUT77086A (sv)
MX (1) MX9704030A (sv)
NO (1) NO972451L (sv)
NZ (1) NZ297342A (sv)
WO (1) WO1996016649A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
US6420401B1 (en) * 1997-08-22 2002-07-16 Wichita State University 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
DOP2000000107A (es) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas
MXPA05003867A (es) * 2002-10-09 2005-11-23 Schering Corp Tiadiazoldioxidos y tiadiazoloxidos como ligandos de receptor cxc-y cc-quimiocina.
CA2511818A1 (en) * 2002-12-30 2004-07-29 Jeffrey O. Saunders Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
US20080045706A1 (en) * 2002-12-31 2008-02-21 Flynn Daniel L Anti-inflammatory medicaments
US7144911B2 (en) * 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) * 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) * 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
EP1694659B8 (en) * 2003-12-19 2008-10-08 Schering Corporation Thiadiazoles as cxc- and cc- chemokine receptor ligands
MXPA06007205A (es) * 2003-12-22 2006-08-31 Schering Corp Dioxidos de isotiazol como ligandos del receptor cxc y cc-quimiocina.
US20070191336A1 (en) * 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
AU2005321946B2 (en) 2004-12-23 2012-08-16 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
WO2007002764A2 (en) * 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
US7897606B2 (en) * 2005-06-29 2011-03-01 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
AU2008242697A1 (en) * 2007-04-20 2008-10-30 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
US20110189167A1 (en) * 2007-04-20 2011-08-04 Flynn Daniel L Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
CA2742007C (en) * 2008-10-29 2014-07-08 Deciphera Pharmaceuticals, Llc Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
KR102196011B1 (ko) * 2013-02-13 2020-12-30 에네오스 가부시키가이샤 윤활유 기유의 제조 방법
US20220267260A1 (en) * 2016-11-29 2022-08-25 Epizyme, Inc. Compounds containing a sulfonic group as kat inhibitors
CA3089566A1 (en) 2018-01-31 2019-08-08 Deciphera Pharmaceuticals, Llc Combination therapy for the treatment of gastrointestinal stromal tumors
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
JP2022544234A (ja) 2019-08-12 2022-10-17 デシフェラ・ファーマシューティカルズ，エルエルシー 胃腸間質腫瘍を治療するためのリプレチニブ
KR20220123058A (ko) 2019-12-30 2022-09-05 데시페라 파마슈티칼스, 엘엘씨. 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
EP4084778B1 (en) 2019-12-30 2023-11-01 Deciphera Pharmaceuticals, LLC Amorphous kinase inhibitor formulations and methods of use thereof
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04507095A (ja) * 1989-05-04 1992-12-10 サノフィ 蛋白分解酵素阻害剤として有用なサッカリン誘導体及びその製造
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE4141218A1 (de) * 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5550139A (en) * 1994-01-03 1996-08-27 The Wichita State University Serine protease inhibitors

Also Published As

Publication number Publication date
WO1996016649A1 (en) 1996-06-06
MX9704030A (es) 1998-02-28
FI972309A (sv) 1997-07-30
AU4248396A (en) 1996-06-19
CA2205970A1 (en) 1996-06-06
EP0793494A1 (en) 1997-09-10
HUT77086A (hu) 1998-03-02
NO972451D0 (no) 1997-05-29
AU703719B2 (en) 1999-04-01
JPH10510535A (ja) 1998-10-13
EP0793494A4 (en) 1998-01-28
CN1173130A (zh) 1998-02-11
US5494925A (en) 1996-02-27
NZ297342A (en) 1999-05-28
NO972451L (no) 1997-07-25

Similar Documents

Publication Publication Date Title
FI972309A0 (sv) 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
FI963566A0 (sv) Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa
IL115563A0 (en) Benzoxazole derivatives and pharmaceutical compositions containing the same
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
EE9800426A (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL112443A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
KR970703779A (ko) 건강 조성물(health composition)
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
BR8806217A (pt) Derivados de 2,2-difluorciclopropiletano,processo para sua preparacao,composicoes praguicidas e aplicacao
FI972306A0 (sv) Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning
FI960316A0 (sv) Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma
HUT77375A (hu) Enterokinetikus hatású benzamidszármazékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
FI956278A (sv) Substituerade 4-fenyltiazolderivat, förfarande för deras framställnin g och farmaceutiska kompositioner innehållande dem
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
ZA945597B (en) Methyiguanidine derivatives process for their preparation and the compositions containing them
FI953956A (sv) 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel
EE9700226A (et) Bensisoksasoolderivaadid ja nimetatud ühendeid sisaldavad pestitsiidsed kompositsioonid
EE9800140A (et) Pestitsiidsed ühendid, koostised ja protsess nende valmistamiseks
FI954743A0 (sv) Sammansättningar med difluormetoxi-2,2,2-trifluoretan
IL115981A (en) Cyclolignan derivatives processes for the preparation thereof and pharmaceutical compositions containing the same